Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Leases: 2019-2024

Historic Current Leases for China Pharma Holdings (CPHI) over the last 6 years, with Dec 2024 value amounting to $39,323.

  • China Pharma Holdings' Current Leases rose 16.74% to $70,326 in Q3 2025 from the same period last year, while for Sep 2025 it was $70,326, marking a year-over-year increase of 16.74%. This contributed to the annual value of $39,323 for FY2024, which is 49.41% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Current Leases is $39,323, which was down 49.41% from $77,727 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Current Leases ranged from a high of $85,282 in FY2021 and a low of $39,323 during FY2024.
  • Moreover, its 3-year median value for Current Leases was $40,445 (2022), whereas its average is $52,498.
  • As far as peak fluctuations go, China Pharma Holdings' Current Leases slumped by 52.57% in 2022, and later skyrocketed by 92.18% in 2023.
  • Over the past 5 years, China Pharma Holdings' Current Leases (Yearly) stood at $52,070 in 2020, then spiked by 63.78% to $85,282 in 2021, then tumbled by 52.57% to $40,445 in 2022, then skyrocketed by 92.18% to $77,727 in 2023, then crashed by 49.41% to $39,323 in 2024.